Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1996 Nov;64(11):4769–4775. doi: 10.1128/iai.64.11.4769-4775.1996

Effect of amplification of the Cap b locus on complement-mediated bacteriolysis and opsonization of type b Haemophilus influenzae.

G J Noel 1, A Brittingham 1, A A Granato 1, D M Mosser 1
PMCID: PMC174444  PMID: 8890238

Abstract

Amplification of the Cap b locus of Haemophilus influenzae occurs frequently in clinical isolates and has been proposed to be a mechanism by which this organism evades host defense. To determine if amplification of this locus affected complement fixation, in vitro studies to determine complement-mediated bacteriolysis and complement-mediated opsonization of an isogenic set of organisms containing 2, 3, and 4 copies of the Cap b locus were performed. Organisms containing 4 copies of the Cap b locus were significantly more resistant to antibody-dependent, classical complement pathway-directed bacteriolysis than were organisms containing 2 copies. Organisms containing 3 copies of this locus exhibited intermediate susceptibility to lysis. Complement-mediated opsonization of these organisms was assessed by determining the degree of binding of bacteria to murine or human macrophages or to nonphagocytic cells transfected with the genes for human Mac-1, the complement receptor type 3. In all three assay systems, organisms containing 4 copies of the Cap b locus bound less well than did organisms containing 2 copies of this locus. Consistent with their decreased susceptibility to lysis and opsonization, organisms with 4 copies of the Cap b locus fixed less C3 than did organisms containing 2 copies. These data demonstrate that amplification of the Cap b locus is associated with decreased susceptibility to complement-mediated lysis and decreased complement-mediated opsonization and suggest that amplification is used by these pathogens to increase their resistance to complement-dependent host defense mechanisms [correction of mecanisms].

Full Text

The Full Text of this article is available as a PDF (290.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson P., Johnston R. B., Jr, Smith D. H. Human serum activities against Hemophilus influenzae, type b. J Clin Invest. 1972 Jan;51(1):31–38. doi: 10.1172/JCI106793. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Corn P. G., Anders J., Takala A. K., Käyhty H., Hoiseth S. K. Genes involved in Haemophilus influenzae type b capsule expression are frequently amplified. J Infect Dis. 1993 Feb;167(2):356–364. doi: 10.1093/infdis/167.2.356. [DOI] [PubMed] [Google Scholar]
  3. Crosson F. J., Jr, Winkelstein J. A., Moxon E. R. Participation of complement in the nonimmune host defense against experimental Haemophilus influenzae type b septicemia and meningitis. Infect Immun. 1976 Oct;14(4):882–887. doi: 10.1128/iai.14.4.882-887.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Gnehm H. E., Pelton S. I., Gulati S., Rice P. A. Characterization of antigens from nontypable Haemophilus influenzae recognized by human bactericidal antibodies. Role of Haemophilus outer membrane proteins. J Clin Invest. 1985 May;75(5):1645–1658. doi: 10.1172/JCI111872. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Hoiseth S. K., Moxon E. R., Silver R. P. Genes involved in Haemophilus influenzae type b capsule expression are part of an 18-kilobase tandem duplication. Proc Natl Acad Sci U S A. 1986 Feb;83(4):1106–1110. doi: 10.1073/pnas.83.4.1106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hondalus M. K., Diamond M. S., Rosenthal L. A., Springer T. A., Mosser D. M. The intracellular bacterium Rhodococcus equi requires Mac-1 to bind to mammalian cells. Infect Immun. 1993 Jul;61(7):2919–2929. doi: 10.1128/iai.61.7.2919-2929.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Kroll J. S., Loynds B. M., Moxon E. R. The Haemophilus influenzae capsulation gene cluster: a compound transposon. Mol Microbiol. 1991 Jun;5(6):1549–1560. doi: 10.1111/j.1365-2958.1991.tb00802.x. [DOI] [PubMed] [Google Scholar]
  8. Kroll J. S., Moxon E. R. Capsulation and gene copy number at the cap locus of Haemophilus influenzae type b. J Bacteriol. 1988 Feb;170(2):859–864. doi: 10.1128/jb.170.2.859-864.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Kroll J. S., Moxon E. R., Loynds B. M. An ancestral mutation enhancing the fitness and increasing the virulence of Haemophilus influenzae type b. J Infect Dis. 1993 Jul;168(1):172–176. doi: 10.1093/infdis/168.1.172. [DOI] [PubMed] [Google Scholar]
  10. Kuratana M., Anderson P. Host metabolites that phenotypically increase the resistance of Haemophilus influenzae type b to clearance mechanisms. J Infect Dis. 1991 May;163(5):1073–1079. doi: 10.1093/infdis/163.5.1073. [DOI] [PubMed] [Google Scholar]
  11. Kuratana M., Hansen E. J., Anderson P. Multiple mechanisms in serum factor-induced resistance of Haemophilus influenzae type b to antibody. Infect Immun. 1990 Apr;58(4):914–919. doi: 10.1128/iai.58.4.914-919.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Mosser D. M., Wedgwood J. F., Edelson P. J. Leishmania amastigotes: resistance to complement-mediated lysis is not due to a failure to fix C3. J Immunol. 1985 Jun;134(6):4128–4131. [PubMed] [Google Scholar]
  13. Moxon E. R., Vaughn K. A. The type b capsular polysaccharide as a virulence determinant of Haemophilus influenzae: studies using clinical isolates and laboratory transformants. J Infect Dis. 1981 Apr;143(4):517–524. doi: 10.1093/infdis/143.4.517. [DOI] [PubMed] [Google Scholar]
  14. Noel G. J., Barenkamp S. J., St Geme J. W., 3rd, Haining W. N., Mosser D. M. High-molecular-weight surface-exposed proteins of Haemophilus influenzae mediate binding to macrophages. J Infect Dis. 1994 Feb;169(2):425–429. doi: 10.1093/infdis/169.2.425. [DOI] [PubMed] [Google Scholar]
  15. Noel G. J., Hoiseth S. K., Edelson P. J. Type b capsule inhibits ingestion of Haemophilus influenzae by murine macrophages: studies with isogenic encapsulated and unencapsulated strains. J Infect Dis. 1992 Jul;166(1):178–182. doi: 10.1093/infdis/166.1.178. [DOI] [PubMed] [Google Scholar]
  16. Noel G. J., Katz S., Edelson P. J. Complement-mediated early clearance of Haemophilus influenzae type b from blood is independent of serum lytic activity. J Infect Dis. 1988 Jan;157(1):85–90. doi: 10.1093/infdis/157.1.85. [DOI] [PubMed] [Google Scholar]
  17. Noel G. J., Mosser D. M., Edelson P. J. Role of complement in mouse macrophage binding of Haemophilus influenzae type b. J Clin Invest. 1990 Jan;85(1):208–218. doi: 10.1172/JCI114414. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Porto M. H., Noel G. J., Edelson P. J. Resistance to serum bactericidal activity distinguishes Brazilian purpuric fever (BPF) case strains of Haemophilus influenzae biogroup aegyptius (H. aegyptius) from non-BPF strains. Brazilian Purpuric Fever Study Group. J Clin Microbiol. 1989 Apr;27(4):792–794. doi: 10.1128/jcm.27.4.792-794.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Quinn P. H., Crosson F. J., Jr, Winkelstein J. A., Moxon E. R. Activation of the alternative complement pathway by Haemophilus influenzae type B. Infect Immun. 1977 Apr;16(1):400–402. doi: 10.1128/iai.16.1.400-402.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Smith A. L., Smith D. H., Averill D. R., Jr, Marino J., Moxon E. R. Production of Haemophilus influenzae b meningitis in infant rats by intraperitoneal inoculation. Infect Immun. 1973 Aug;8(2):278–290. doi: 10.1128/iai.8.2.278-290.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Tarr P. I., Hosea S. W., Brown E. J., Schneerson R., Sutton A., Frank M. M. The requirement of specific anticapsular IgG for killing of Haemophilus influenzae by the alternative pathway of complement activation. J Immunol. 1982 Apr;128(4):1772–1775. [PubMed] [Google Scholar]
  22. Weiser J. N. Relationship between colony morphology and the life cycle of Haemophilus influenzae: the contribution of lipopolysaccharide phase variation to pathogenesis. J Infect Dis. 1993 Sep;168(3):672–680. doi: 10.1093/infdis/168.3.672. [DOI] [PubMed] [Google Scholar]
  23. Weller P. F., Smith A. L., Anderson P., Smith D. H. The role of encapsulation and host age in the clearance of Haemophilus influenzae bacteremia. J Infect Dis. 1977 Jan;135(1):34–41. doi: 10.1093/infdis/135.1.34. [DOI] [PubMed] [Google Scholar]
  24. Wessels M. R., Butko P., Ma M., Warren H. B., Lage A. L., Carroll M. C. Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity. Proc Natl Acad Sci U S A. 1995 Dec 5;92(25):11490–11494. doi: 10.1073/pnas.92.25.11490. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES